Actafarma Laboratories has a new partner in the European international scene. The ties with southern europe become narrow and they have signed a five-year collaboration between Centurion Pharma and Actafarma Laboratories.
This introduction to the Turkish market, not only favors a chance of success for both partners, but it facilitates the access of consumers in this country for innovative and proven solutions. Therapeutic lines which will start market penetration are: Prevention & Longevity, and Joint Mobility and.
Our new partner with over 65 years of industry experience, has not only the baggage that give years, he also has a major interest in the development of the research area.
It is for this reason that in this new business relationship, it aims not only to transfer all the knowledge of Actafarma Laboratories on the development of the brand and focused on the specific needs of the Turkish inhabitants products, but also get feedback from such a practiced partner in the development of new therapeutic trends and in order to keep improving the therapeutic lines, which together will innovate for new market solutions.